New progresses in hepatitis C management

Authors

  • Alfredo Enrique Arredondo Bruce Hospital Provincial Docente Amalia Simoni Universidad Médica Carlosn J Finlay
  • Ion Prez Trujillo Hospital Provincial Docente Amalia Simoni
  • Alfredo Enrique Arredondo Rubido Universidad de Ciencias Medicas Calos J Finlay. Hospital Provincial Docene Amalia Simoni

Keywords:

hepatitis C virus, chronic hepatitis C, interferon, antivirals

Abstract

The hepatitis C virus is the main infection transmitted by blood products in the United States, with 3.2 million of infected individuals. The injected alpha interferon has historically been the key stone in the therapy of the hepatitis C virus. The works published in Medline, Scielo, PubMed and Hinary until the beginning of 2016 were reviewed. The main used key words were HVC, cronic hepatitis C, interferon, antivirals. Recent advances have led to the availability on new antiviral drugs, developing new interferon-free oral therapies that make the therapy of hepatitis C virus more efficacious and make easier the treatment regimens. Although these treatment regimens are still complicated, the new recommendations and guidelines evolve quickly. The fast development of new therapies against hepatitis C has led to more efficacious methods with less adverse reactions, optimizing the treatment of these patients.

Downloads

Download data is not yet available.

Author Biographies

Alfredo Enrique Arredondo Bruce, Hospital Provincial Docente Amalia Simoni Universidad Médica Carlosn J Finlay

Edspecialista de 2O grado en MedicinaInterna

Profesor Consultante

Jefe Catedra Clinica

Ion Prez Trujillo, Hospital Provincial Docente Amalia Simoni

E

Profesor Asistente. Especialista en 1er grado en Gastroenterologia

Downloads

Published

2018-03-19

How to Cite

1.
Arredondo Bruce AE, Trujillo IP, Rubido AEA. New progresses in hepatitis C management. Rev Méd Electrón [Internet]. 2018 Mar. 19 [cited 2025 Mar. 12];40(2):383-9. Available from: https://revmedicaelectronica.sld.cu/index.php/rme/article/view/1899

Issue

Vol. 40 No. 2 (2018)

Section

Review article

License

All content published in this journal is Open Access, distributed under the terms of the CC BY-NC 4.0 License.

It allows:

 - Copy and redistribute published material in any medium or format.

 - Adapt the content.

 This will be done under the following terms:

 - Attribute the authors' credits and indicate whether changes were made, in which case it must be in a reasonable way.

 - Non-commercial use.

 - Recognize the journal where it is published.

 The copyrights of each article are maintained, without restrictions.